| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-09-17 |
4 |
AS |
$15.02 |
$58,578 |
D/D |
(3,900) |
326,705 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-09-16 |
4 |
AS |
$15.07 |
$167,277 |
D/D |
(11,100) |
330,605 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-26 |
4 |
AS |
$16.57 |
$3,016 |
D/D |
(182) |
341,705 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-24 |
4 |
AS |
$15.22 |
$1,568 |
D/D |
(103) |
341,887 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-06 |
4 |
AS |
$17.69 |
$394,487 |
D/D |
(22,300) |
341,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-18 |
4 |
AS |
$17.96 |
$3,897 |
D/D |
(217) |
345,912 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-12 |
4 |
AS |
$17.96 |
$590,884 |
D/D |
(32,900) |
346,129 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-02-22 |
4 |
AS |
$13.45 |
$11,258 |
D/D |
(837) |
357,584 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-11-29 |
4 |
AS |
$15.22 |
$2,770 |
D/D |
(182) |
358,421 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-11-23 |
4 |
AS |
$15.20 |
$1,550 |
D/D |
(102) |
358,603 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-25 |
4 |
AS |
$17.47 |
$3,686 |
D/D |
(211) |
363,892 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-21 |
4 |
AS |
$17.70 |
$16,001 |
D/D |
(904) |
364,103 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-05 |
4 |
AS |
$17.67 |
$45,659 |
D/D |
(2,584) |
364,290 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-19 |
4 |
AS |
$17.86 |
$3,876 |
D/D |
(217) |
365,007 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,312 |
365,224 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-03 |
4 |
AS |
$22.07 |
$333,610 |
D/D |
(15,116) |
366,874 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-02-28 |
4 |
AS |
$13.85 |
$2,521 |
D/D |
(182) |
367,498 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-02-23 |
4 |
AS |
$13.26 |
$1,353 |
D/D |
(102) |
367,680 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,198 |
367,782 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-11 |
4 |
AS |
$17.95 |
$1,795 |
D/D |
(100) |
379,029 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-07-26 |
4 |
AS |
$24.25 |
$485,000 |
D/D |
(20,000) |
381,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-07-05 |
4 |
AS |
$20.35 |
$323,565 |
D/D |
(15,900) |
387,001 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-11-20 |
4 |
AS |
$17.75 |
$4,029 |
D/D |
(227) |
387,105 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-11-19 |
4 |
AS |
$18.17 |
$7,213 |
D/D |
(397) |
387,332 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-11-17 |
4 |
AS |
$17.65 |
$3,812 |
D/D |
(216) |
387,729 |
0 |
- |
|
173 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
